ICM
RYN icon

Invenomic Capital Management’s Rayonier RYN Stock Holding History

Invenomic Capital Management’s Portfolio RYN Stock Details RYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-467,916
Closed -$9.9M – 179
2025
Q2 		$9.9M Buy
+467,916
New +$10.7M 0.56% 65

Other funds holding RYN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invenomic Capital Management's RYN Position: Q3 2025 in Review

Invenomic Capital Management sold out of Rayonier (RYN) in Q3 2025, closing a stake of 467,916 shares — an estimated $9.9M sold.

Invenomic Capital Management first reported a position in RYN in Q2 2025 and held it in 1 quarter. The position peaked at $9.9M in Q2 2025. 367 funds tracked by Wall St. Rank hold RYN as of Q3 2025.

  • Invenomic Capital Management reported no remaining Rayonier position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 467,916 Rayonier shares in Q3 2025, an estimated $9.9M.
  • Invenomic Capital Management first reported a position in Rayonier in Q2 2025 and held it in 1 quarter.
  • Invenomic Capital Management's Rayonier position peaked at $9.9M in Q2 2025.
  • 367 funds tracked by Wall St. Rank held Rayonier as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.